Randomized trial of dietary fiber andLactobacillus casei administration for prevention of colorectal tumors

Abstract

The epidemiologic evidence that dietary fiber protects against colorectal cancer is equivocal. No large-scale clinical study of the administration of Lactobacillus casei has been reported. We examined whether dietary fiber and L. casei prevented the occurrence of colorectal tumors. Subjects were 398 men and women presently free from tumor who had had at least 2 colorectal tumors removed. Subjects were randomly assigned to 4 groups administered wheat bran, L. casei, both or neither. The primary end point was the presence or absence of new colorectal tumor(s) diagnosed by colonoscopy after 2 and 4 years. Among 380 subjects who completed the study, 95, 96, 96 and 93 were assigned to the wheat bran, L. casei, both and no treatment groups, respectively. Multivariate adjusted ORs for occurrence of tumors were 1.31 (95% CI 0.87-1.98) in the wheat bran group and 0.76 (0.50-1.15) in the L. casei group compared to the control group. There was a significantly higher number of large tumors after 4 years in the wheat bran group. The occurrence rate of tumors with a grade of moderate atypia or higher was significantly lower in the group administered L. casei. No significant difference in the development of new colorectal tumors was observed with administration of either wheat bran or L. casei. However, our results suggest that L. casei prevented atypia of colorectal tumors. ' 2005 Wiley-Liss, Inc.

Flexible cytokine production by macrophages and T cells in response to probiotic bacteria: A possible mechanism by which probiotics exert multifunctional immune regulatory activities

“…Clinical trials showed that administration of LcS prevented the recurrence of superficial bladder cancer and colorectal tumors. [10][11][12] A communitybased field trial exhibited the efficacy of LcS-containing fermented milk in preventing acute diarrhea caused by enteric pathogens in children. 13 Synbiotic treatment using LcS prevented postoperative infectious complications in biliary cancer surgery.…”

275 The Role of Curcumin in Modulating Colonic Microbiota During Colitis and Colon Cancer Prevention

“…Although the results of systematic and wellcontrolled clinical studies in CRC prevention are not yet available, published reports suggest cautious optimism. [58][59][60] Although our study design does not address causality, it is plausible that curcumin contributes to chemoprevention via expansion of the native Lactobacilli in the context of overall increase of colonic microbiome richness. Similar effects may be ascribed to increased Bifidobacteria, which have also been shown to reduce aberrant crypt foci in mice receiving dimethylhyrazine.…”

A clinical primer of the role of gut microbiome in health and disease

“…Lactobacillus johnsonii and Lactobacillus casei suppress CRC tumor growth in patients and modulate the intestinal immune response. 110,111 Antibiotics have long been used to eradicate H pylori in the upper GI tract, and treatment is associated with a significant reduction in gastric Another growing area of interest is in modulating the gut microbiota to prevent toxicity associated with the chemotherapy and radiation used to treat cancer. A recent study identified the role of bacterial beta-glucuronidase in mediating GI toxicity of a common drug used for colon cancer CPT-11.…”